bb2121 (idecabtagene vicleucel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bb2121 (idecabtagene vicleucel), covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma [Phase 2]